TruNativ, a science-driven everyday nutrition brand, has announced the successful closure of its Series B funding round, raising approximately $30 million. The round was led by OrbiMed, one of the world’s largest healthcare-focused investment firms, and included a combination of primary capital infusion and secondary share sales by early investors. This investment represents a pivotal step in TruNativ’s growth journey, reinforcing its mission to build India’s most trusted nutrition platform while expanding consumer access to clean, scientifically validated nutrition solutions nationwide.
The fresh capital will be used to accelerate TruNativ’s growth across key strategic areas, including expanding its nationwide presence through direct-to-consumer (D2C), quick commerce, modern trade, pharmacy, and other retail channels. The company also plans to further scale its B2B2C ingredient business, which currently supports nutrition offerings for several leading consumer brands across India.
Established in 2019 in Mumbai by mother-son entrepreneurs, Pranav Malhotra and Mamta Malhotra, TruNativ has evolved from offering a single sugar-replacement product into a comprehensive clean-label nutrition platform. Trunativ’s portfolio now spans sugar alternatives, protein, gut health, and wellness solutions. The brand has emerged as a category leader, commanding a majority share of the sugar replacement segment on quick-commerce platforms and securing the top position in the dietary fibre and sweeteners categories on Amazon India.
Pranav Malhotra, Co-Founder & CEO, TruNativ, said, “India’s nutrition transformation is not a trend, it is a reckoning. For decades, Indian consumers have been underserved: overexposed to sugar, protein deficiency, and dependent on products that promise health but deliver compromise. We built TruNativ to fix that for every household, not just the health-conscious few. OrbiMed’s investment signals that preventive nutrition is no longer a wellness trend – it is a healthcare imperative. Our commitment is to make India a global leader in nutrition innovation, not just a consumer of it.”
Commenting on the investment, Dr. Sunny Sharma, Senior Managing Director, OrbiMed Asia said, “We share Pranav’s passion for improving nutrition nationwide and enhancing health outcomes through healthier daily dietary habits. OrbiMed is excited to partner with TruNativ as it builds a leading consumer health business.”
Dr. Sharma and Sumona Chakraborty of OrbiMed will be joining the company’s board.
OrbiMed’s investment underscores the growing potential of India’s nutrition and preventive healthcare sector, driven by rising consumer focus on healthier lifestyles and proactive wellness. As demand for clean-label, science-backed nutrition products continues to gain momentum, TruNativ’s strong market position, category leadership, and innovation-driven strategy place it in a favourable position to capture this growth and help redefine the future of everyday nutrition in India.
The transaction was advised exclusively by PwC, which served as TruNativ’s financial advisor throughout the funding process.
